7 November 2014: promotion of an unlicensed medicine
Updated 31 March 2015
© Crown copyright 2015
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/advertising-investigations-november-2014/7-november-2014-promotion-of-an-unlicensed-medicine
Dickson Chemist complained to MHRA about a website for Low Dose Naltrexone (LDN) produced by LDN Surgery. The complainant was concerned that the website promoted an unlicensed medicine.
MHRA upheld the complaint and LDN Surgery agreed to make changes to their website to ensure unlicensed medicines were not promoted.